Cite
HARVARD Citation
Gupta, P. et al. (2021). Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Stem cells translational medicine. pp. 1602-1613. [Online].